US 8247532
Deuterated hepatitis C protease inhibitors
granted A61PA61P31/12A61P31/14
Quick answer
US patent 8247532 (Deuterated hepatitis C protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/12, A61P31/14, A61P43/00